The Least Fit Fifth of 122,007 Patients Died at Five Times the Rate of the Fittest. Being Out of Shape Carried More Risk Than Smoking, Diabetes or Heart Disease, and Almost Nobody Measures It.
Ask a man over 40 for his cholesterol and he can usually tell you. Ask for his VO2 max and he will look at you blankly, which is strange, because in the largest datasets ever assembled on the question, how far a man can push himself on a treadmill predicts when he will die better than his cholesterol, his blood pressure, his smoking history or whether he already has heart disease. The Cleveland Clinic followed 122,007 patients for a median of 8.4 years and found a fivefold mortality gap between the least fit and the fittest. The Veterans Affairs system followed 750,302 people and found a fourfold gap with no ceiling on the benefit. The American Heart Association looked at this record in 2016 and asked physicians to start measuring fitness as a vital sign. Almost none do. This article is about what cardiorespiratory fitness actually is, how strongly it predicts survival, how fast it declines with age, how much of it can be recovered with training, what it does and does not do to testosterone, and why a man losing weight on a GLP-1 medication needs to think about it more carefully than anyone else.
Key Takeaways: What the Fitness Evidence Actually Shows
In the Cleveland Clinic study of 122,007 adults published in JAMA Network Open in 2018, patients in the lowest fitness group had an adjusted hazard ratio of 5.04 for all-cause death compared with the elite group, and the risk attached to low fitness exceeded the risk attached to smoking (1.41), diabetes (1.40) or coronary artery disease (1.29). In 750,302 United States veterans aged 30 to 95 followed for a median of 10.2 years, the least fit fifth had a hazard ratio of 4.09 versus the extremely fit, and the benefit kept rising through the highest fitness category with no observed upper limit. A meta-analysis of 33 studies and 102,980 people found that each additional MET of fitness, roughly 3.5 mL of oxygen per kilogram per minute, was associated with 13 percent lower all-cause mortality and 15 percent lower cardiovascular mortality. Peak oxygen uptake falls 3 to 6 percent per decade in the twenties and thirties and more than 20 percent per decade after 70, according to the Baltimore Longitudinal Study of Aging. Eight weeks of four-by-four-minute interval training at 90 to 95 percent of maximum heart rate raised VO2 max by 7.2 percent in a Norwegian trial, and 20 weeks of cycling raised it by an average of roughly 15 to 20 percent in the HERITAGE Family Study with wide individual variation. No randomized trial has been large enough to prove that raising fitness lowers mortality, and the strongest attempt, the Generation 100 study of 1,567 older Norwegians, showed a numerical but not statistically significant advantage for high-intensity training.
The Steepest Step Is the First One
Age-adjusted all-cause death rates per 10,000 person-years by fitness quintile from the Aerobics Center Longitudinal Study, published in JAMA in 1989. Blair and colleagues gave 10,224 men and 3,120 women a maximal treadmill test at the Cooper Clinic in Dallas and followed them for an average of 8 years. In men the death rate fell from 64.0 in the least fit fifth to 18.6 in the fittest, and the largest single drop came between the first and second quintile. In women it fell from 39.5 to 8.5. The gradient was present after adjustment for age, smoking, cholesterol, blood pressure, fasting glucose and family history. This was the study that put cardiorespiratory fitness on the map as a mortality predictor, and every larger cohort since has reproduced its shape: most of the benefit comes from leaving the bottom fifth.
- Men (n = 10,224)
- Women (n = 3,120)
What is cardiorespiratory fitness and how is it measured?
Cardiorespiratory fitness is the maximum rate at which a person's heart, lungs, blood and muscles can deliver and use oxygen during hard exercise, and it is measured as VO2 max in millilitres of oxygen per kilogram of body weight per minute or estimated in METs from a treadmill test. One MET is the oxygen cost of sitting still, defined as 3.5 mL per kilogram per minute, so a man with a VO2 max of 35 has a capacity of 10 METs. The gold standard is a graded exercise test with gas analysis, in which the subject runs or cycles against rising resistance until exhaustion while a mask measures oxygen consumed. Most large mortality studies did not use gas analysis. The Cleveland Clinic cohort and the Veterans Affairs cohort estimated METs from the final treadmill stage reached under the Bruce protocol, which is less precise but tracks measured VO2 max closely enough to sort people into fitness bands. Typical values for a 45-year-old man run from the low 30s for a sedentary office worker to the mid 40s for a regular runner, with competitive endurance athletes above 60. The number is not fixed. It reflects stroke volume, blood volume, capillary density in muscle, mitochondrial content and the ability of muscle fibres to extract oxygen, and every one of those responds to training. That is what makes cardiorespiratory fitness different from most risk factors: it is a measurement of the body's current condition rather than a fixed trait, and it moves in both directions within weeks.
How strongly does fitness predict how long a man lives?
Cardiorespiratory fitness predicts all-cause mortality more strongly than any conventional risk factor, and it has done so in every large cohort since the first one was published in 1989. That first study, from the Aerobics Center Longitudinal Study in Dallas, followed 10,224 men and 3,120 women for an average of 8 years after a maximal treadmill test. Age-adjusted death rates in men fell from 64.0 per 10,000 person-years in the least fit fifth to 18.6 in the fittest fifth, and the largest single drop came between the first and second quintile, from 64.0 to 25.5. Myers and colleagues confirmed the pattern in 6,213 men referred for treadmill testing at the Palo Alto Veterans Affairs hospital, reported in the New England Journal of Medicine in 2002. Exercise capacity was the strongest predictor of death among every variable measured, each additional MET was associated with a 12 percent improvement in survival, and men below 5 METs had roughly twice the death rate of men above 8. The Cleveland Clinic study in 2018 scaled the question up to 122,007 patients tested between 1991 and 2014, with 13,637 deaths over a median follow-up of 8.4 years. Patients were sorted into five fitness groups by age and sex percentile: low, below average, above average, high and elite, with elite defined as the top 2.3 percent. The adjusted hazard ratio for low versus elite was 5.04. The Veterans Affairs cohort published in the Journal of the American College of Cardiology in 2022 was larger still, 750,302 people aged 30 to 95 with 174,807 deaths over a median of 10.2 years, and it found a hazard ratio of 4.09 for the least fit versus the extremely fit, with the gradient holding in every age band, both sexes and every racial group examined. A meta-analysis by Kodama and colleagues in JAMA in 2009, covering 33 studies and 102,980 people, put the dose-response at 13 percent lower all-cause mortality and 15 percent lower cardiovascular mortality per MET.
Low Fitness Next to the Risk Factors Everyone Measures
Adjusted hazard ratios for all-cause death from Mandsager and colleagues in JAMA Network Open in 2018, all drawn from the same multivariable model in 122,007 Cleveland Clinic patients tested on a treadmill between 1991 and 2014 and followed for a median of 8.4 years, during which 13,637 died. Fitness groups were defined by age and sex percentile, with elite meaning the top 2.3 percent. The dashed line at 1.0 means no added risk. Low fitness relative to elite carried a hazard ratio of 5.04, and because it compares the extremes it describes a wider exposure gap than the other bars. The fairer comparison is the second bar: being below average rather than above average carried a hazard ratio of 1.41, identical to smoking. Even the high fitness group, sitting just below elite, carried 25 percent more risk than the elite group, which is where the no-upper-limit finding comes from.
Is being unfit really worse than smoking or diabetes?
In the Cleveland Clinic data, yes, and by a wide margin. Mandsager and colleagues reported the adjusted hazard ratios for the conventional risk factors inside the same model that produced the fitness estimates, which makes the comparison direct. Smoking carried a hazard ratio of 1.41, diabetes 1.40 and established coronary artery disease 1.29. Being below average in fitness rather than above average carried a hazard ratio of 1.41, the same as smoking. Being in the low fitness group rather than the elite group carried 5.04. The comparison should be read carefully. The fitness groups compare extremes, while smoking compares smokers with everyone else, so the 5.04 figure describes a wider gap in exposure than the 1.41 for smoking does. Even so, the below-average-versus-above-average figure describes two adjacent groups near the middle of the distribution, and it matched smoking exactly. Two features of the fitness result make it unusually hard to dismiss. First, the estimates were adjusted for age, sex, body mass index, hypertension, diabetes, coronary disease, smoking, kidney disease, medications and other covariates, so the fitness effect is what remained after those were accounted for. Second, the gradient did not flatten in older patients. In patients 70 and older the elite group still had a hazard ratio of 0.71 relative to the high group, and in patients with hypertension it was 0.70. The signal that fitness carries is not explained by the risk factors it correlates with, and it does not weaken with age.
Is there an upper limit to the benefit?
No upper limit has been found in any cohort large enough to look for one, which contradicts the widely repeated claim that extreme exercise starts to harm the heart. The Cleveland Clinic study was designed partly to answer this question, since earlier work had suggested a plateau or a U-shaped curve at very high fitness. The elite group, defined as two standard deviations above the mean for age and sex, had the lowest mortality of all five groups, with a hazard ratio of 0.80 relative to the high group. The Veterans Affairs cohort found the same thing at larger scale. Its extremely fit group, at or above the 98th percentile, had lower mortality than the high fit group just below it, and the authors stated plainly that there was no evidence of an upper threshold. This does not mean that more exercise is always better in every respect. Endurance athletes accumulate more coronary calcium and more atrial fibrillation than moderately active people, and those findings are real. What the mortality data shows is that whatever harm high fitness does is outweighed, on the outcome that matters most, by whatever good it does. For a man over 40 the practical implication runs the other way from where the ceiling debate usually points. The steepest part of the curve is at the bottom. Moving from the least fit fifth to the next fifth produced the largest single drop in death rate in the 1989 Dallas study and in every cohort since, and the marginal gain from each further step is smaller. The first hour a week of hard breathing buys more than the tenth.
Does fitness still matter if a man is overweight?
Fitness matters more than weight, according to the meta-analysis that put the two head to head. Barry and colleagues pooled 10 studies with 92,986 participants in Progress in Cardiovascular Diseases in 2014 and stratified everyone by both fitness and body mass index. Unfit individuals had roughly twice the mortality risk of fit individuals regardless of whether they were normal weight, overweight or obese. Fit individuals who were overweight or obese had mortality risk similar to fit individuals of normal weight. Unfit normal-weight individuals had higher risk than fit obese individuals. The pattern has held in the Veterans Affairs data too, where fitness predicted survival within every body mass index band. There is an important caveat that the fat-but-fit phrase tends to obscure. Fitness is expressed per kilogram of body weight, so carrying extra fat lowers a man's measured VO2 max even if his heart and lungs are unchanged, and obese men are far less likely to be fit in the first place. Only a minority of obese adults in these cohorts met the fit threshold. The finding is not that weight does not matter. It is that among men who have already achieved fitness, weight adds little further risk, and among men who have not, losing weight without gaining fitness leaves most of the risk on the table. That last point is the one a man losing weight on a GLP-1 medication needs to hold onto.
How fast does VO2 max decline with age?
Peak oxygen uptake falls by roughly 3 to 6 percent per decade in the twenties and thirties, then the decline accelerates in each subsequent decade and exceeds 20 percent per decade after age 70. Those figures come from Fleg and colleagues in Circulation in 2005, who tested 810 healthy volunteers in the Baltimore Longitudinal Study of Aging repeatedly over time rather than comparing different age groups once, which is the only way to measure a true rate of decline. The acceleration was present in both sexes and was steeper in men than women in absolute terms because men start higher. Cross-sectional studies had previously estimated a steady loss of about 10 percent per decade, and the longitudinal data showed that figure is roughly right on average but wrong in shape: the loss is gentle in midlife and severe in old age. The mechanism is partly cardiac, since maximum heart rate falls by about one beat per year and stroke volume declines, and partly peripheral, as muscle mass and mitochondrial density shrink. The shape of the curve matters for planning. A sedentary man with a VO2 max of 42 at 25 might sit near 38 at 45 and 34 at 55, still comfortable, then fall through 29 at 65 and 23 at 75 and find that climbing stairs has become an effort. The threshold at which everyday life starts to fail is around 5 METs, or 17.5 mL per kilogram per minute, the level below which Myers found death rates doubled. A man who starts with a higher peak and a slower decline reaches that threshold a decade or more later, if at all. Training does not stop the decline, but it shifts the whole curve upward, and masters athletes who keep training lose fitness at a rate closer to 5 percent per decade than 10.
The Curve Bends Down After 60
Illustrative VO2 max trajectories in mL per kilogram per minute, built by applying the per-decade decline rates from Fleg and colleagues in Circulation in 2005 to a sedentary man starting at 42 and a trained man starting at 50. The Baltimore Longitudinal Study of Aging tested 810 healthy volunteers repeatedly over time and found peak oxygen uptake fell 3 to 6 percent per decade in the twenties and thirties, roughly 10 percent per decade in midlife, and more than 20 percent per decade after 70. The dashed line marks 5 METs, or 17.5 mL per kilogram per minute, the level below which Myers and colleagues found death rates roughly doubled in 6,213 men in the New England Journal of Medicine in 2002, and the level at which stairs and shopping start to feel like exertion. The trained line uses the same percentage declines and reaches that floor more than a decade later. These are model curves, not measured individuals, and real trajectories vary widely.
- Sedentary, starts at 42
- Trained, starts at 50
How much can training raise VO2 max, and how quickly?
Structured aerobic training raises VO2 max by roughly 10 to 20 percent over three to five months in previously sedentary adults, with the first gains appearing within a few weeks and large differences between individuals. The best evidence on the average response is the HERITAGE Family Study, which put 481 sedentary adults from 98 families through 20 weeks of supervised cycling three times a week. Mean VO2 max rose by roughly 15 to 20 percent, about 400 mL per minute, but the range ran from essentially zero to gains above 40 percent, and roughly half of the variation in response was heritable. A meaningful minority gained almost nothing despite completing every session. That heterogeneity is why a man should measure his own response rather than assume the average. The best evidence on intensity is a Norwegian trial by Helgerud and colleagues in Medicine and Science in Sports and Exercise in 2007, which randomized 40 moderately trained men to 8 weeks of one of four protocols matched for total work: long slow distance at 70 percent of maximum heart rate, lactate threshold running at 85 percent, 15-second intervals at 90 to 95 percent, or four 4-minute intervals at 90 to 95 percent with 3-minute recoveries. The four-by-four group improved VO2 max by 7.2 percent and the 15-second group by 5.5 percent, while the two lower-intensity groups did not significantly change. Stroke volume rose in the interval groups and not in the others. The protocol is simple enough to run on a hill, a rower or a bike: warm up, four minutes hard enough that talking is impossible, three minutes easy, repeat four times, twice a week. Older men respond too. Fitness gains in the seventies are smaller in absolute terms but similar in percentage terms, and the mortality gradient in the Veterans Affairs cohort was as steep above 70 as below it.
Does aerobic fitness raise testosterone?
Modestly, in sedentary or overweight men, and mostly through fat loss, and in highly trained endurance athletes resting testosterone often runs lower rather than higher. The two findings sound contradictory and are not. Small trials of 6 to 12 weeks of aerobic exercise in previously inactive men have reported increases in total testosterone on the order of 10 to 20 percent, and the gain tracks reductions in fat mass and insulin resistance rather than fitness itself. Kumagai and colleagues showed in 2016 that in overweight and obese Japanese men on a 12-week lifestyle program, increased physical activity raised testosterone more than reduced calorie intake did, even at similar weight loss, which suggests the exercise adds something beyond the fat loss. At the other end of the spectrum, Hackney has documented for three decades that men who train at high endurance volumes for years have resting testosterone 20 to 30 percent below sedentary controls, a pattern he termed the exercise-hypogonadal male condition, with no impairment of fertility and no clear clinical consequence. A single hard session produces a transient rise in testosterone lasting under an hour, similar to the transient growth hormone spike after a sauna, and equally meaningless for resting levels. The practical reading for a man over 40 is that aerobic training is not a testosterone intervention. It supports testosterone indirectly by reducing visceral fat and improving insulin sensitivity, both of which suppress the axis when they go wrong, and the sleep improvements that come with training help too. A man with genuinely low testosterone confirmed on morning bloods will not fix it on a bike, and a man with normal testosterone will not push it higher.
How does GLP-1 weight loss interact with fitness?
GLP-1 weight loss raises measured fitness per kilogram automatically, because the same heart and lungs are moving a lighter body, but it can leave absolute fitness unchanged or lower if a man loses muscle without training. The clearest functional data comes from STEP-HFpEF, published in the New England Journal of Medicine in 2023, which randomized 529 adults with obesity and heart failure with preserved ejection fraction to 2.4 mg of semaglutide weekly or placebo for 52 weeks. Body weight fell 13.3 percent on semaglutide versus 2.6 percent on placebo. Six-minute walk distance improved by 21.5 metres on semaglutide versus 1.2 metres on placebo, and the heart failure symptom score improved by 16.6 points versus 8.7. Walking distance is not VO2 max, but it is the same direction, and it confirms that shedding fat improves how the cardiovascular system performs under load. The concern is the composition of the weight lost. In the STEP 1 body composition substudy, roughly 40 percent of the weight lost on semaglutide was lean mass, which is in line with any rapid weight loss but is a larger absolute loss than diet alone usually produces because the total loss is larger. Muscle is where oxygen is used, so losing it reduces the peripheral half of the fitness equation. The men who come out of a GLP-1 course fitter are the ones who train while on it, and the ones who come out with a lower absolute VO2 max are the ones who did not. Lower doses spread over longer periods, the microdosing approach discussed elsewhere on this site, produce slower weight loss that is easier to pair with training, and the fitness and body composition case for that approach is stronger than the appetite case. The rule is short: if a man is losing weight on a GLP-1 medication and not doing something that makes him breathe hard at least twice a week, he is converting one risk factor into another.
What Losing 13 Percent of Body Weight Did to Walking Distance
Changes from baseline to week 52 in STEP-HFpEF, published in the New England Journal of Medicine in 2023, which randomized 529 adults with obesity and heart failure with preserved ejection fraction to semaglutide 2.4 mg weekly or placebo. Body weight fell 13.3 percent on semaglutide versus 2.6 percent on placebo. Six-minute walk distance improved by 21.5 metres versus 1.2 metres, and the Kansas City Cardiomyopathy Questionnaire clinical summary score, a measure of heart failure symptoms and physical limitation, improved by 16.6 points versus 8.7. Walking distance is a functional proxy rather than a VO2 max measurement, and the trial population was sicker than the typical man losing weight for metabolic reasons, but the direction is clear: shedding fat improves how the cardiovascular system performs under load. Whether absolute fitness rises or falls depends on how much of the lost weight was muscle, which is the argument for training during any GLP-1 course.
- Semaglutide 2.4 mg
- Placebo
Is the mortality link causal, or do healthy men just test fitter?
Partly causal and partly confounded, and the honest answer is that no trial has been large enough to separate the two. Reverse causation is the central problem with every fitness cohort. A man with early heart failure, undiagnosed cancer, chronic lung disease or depression will stop at a lower treadmill stage, and some of those men will die within the follow-up period for reasons that have nothing to do with their fitness. Investigators handle this by excluding deaths in the first year or two of follow-up and by adjusting for known disease, and the gradient survives both, but neither step can remove a condition that has not yet been diagnosed. The mechanistic case for causation is stronger than for most observational findings because fitness improves nearly everything on the risk-factor list at once: blood pressure, insulin sensitivity, triglycerides, HDL cholesterol, resting heart rate, endothelial function and inflammatory markers all move in the right direction within months of training. The one randomized trial with a mortality endpoint is Generation 100, published in the BMJ in 2020, which assigned 1,567 Norwegians aged 70 to 77 to five years of supervised high-intensity intervals, moderate continuous training or general activity advice. All-cause mortality was 3.0 percent in the interval group, 5.9 percent in the moderate group and 4.7 percent in the control group. The difference favoured intervals but did not reach statistical significance, partly because the control group, told simply to follow national guidelines, exercised enough to be fitter than the average Norwegian of that age. A trial powered to prove that raising fitness lowers death would need tens of thousands of participants, a decade of supervised training and a control group willing to stay sedentary, which is why it does not exist. Anyone waiting for that trial before training is waiting for something that will not come.
How should a man over 40 use this evidence?
Measure the number, get out of the bottom fifth as the first priority, and treat everything beyond that as a diminishing but real return. The evidence supports fitness as a mortality predictor better than it supports any single supplement, peptide or hormone protocol discussed on this site, and it is the only item on that list that a man can improve for free in eight weeks. Four practical points follow. First, get a baseline. A gas-analysis VO2 max test at a sports medicine clinic costs about the price of a set of blood tests and takes twenty minutes, and a fitness watch estimate is a rough but usable substitute for tracking change. The number that matters is where a man sits on the age and sex percentile, since that is how every cohort in this article defined risk. Second, the minimum effective dose is intensity, not duration. Two sessions a week of four-by-four-minute intervals at 90 to 95 percent of maximum heart rate raised VO2 max 7.2 percent in eight weeks in the Norwegian trial, and a man who cannot manage that can start with hill walks that leave him unable to talk. Third, fitness is not a hormone intervention. It supports testosterone by reducing visceral fat and improving insulin sensitivity, and it will not raise a low level into the normal range on its own. Fourth, if a GLP-1 medication is part of the plan, the fitness case for pairing it with training and a slower dose escalation is not optional. The weight comes off either way. Whether the man underneath it is more or less capable at the end depends on what he did during the months in between. The cohort data on fitness is observational and the causal question is open, and it is also the most consistent, most graded and most physiologically plausible mortality signal in preventive medicine. Anyone with a cardiac history, chest pain on exertion or uncontrolled blood pressure should have a physician's clearance before starting high-intensity work, and the first session should be easier than it needs to be.
The Fitness Record on One Axis
Every strand of the cardiorespiratory fitness case arranged on a single schematic scale. Green marks what the evidence supports, amber marks design limits that are real without being disqualifying, rose marks findings that count against an unqualified recommendation, and dark grey marks claims the evidence does not carry. Fitness has the largest, most graded and most consistent mortality association of any measurable trait in preventive medicine, a plausible mechanism through every conventional risk factor, and a training response measurable in weeks. What it does not have is a randomized trial large enough to prove that raising it lowers death, a hormonal effect worth the name, or any guarantee that a man losing weight quickly will keep the muscle that produces the number.
Frequently Asked Questions
Have more questions? Contact us or explore our full peptide intelligence platform.
Related Articles
Does Telomere Length Determine Lifespan? Short Telomeres Track With Earlier Death. The Genetics Say Longer Ones Raise Cancer Risk.
Does telomere length determine lifespan? Short telomeres track with earlier death, yet genetic studies show longer ones raise the risk of several cancers.
Low-Dose Aspirin Added 8 Percent to Male Mouse Lifespan. In 19,114 Healthy Older Adults, It Added No Healthy Years and Deaths Ran Higher.
Does low-dose aspirin help longevity? It extended male mouse lifespan 8%, but the ASPREE trial in 19,114 healthy older adults found no gain and more bleeding.
Is NAD+ a Peptide? No. It Is a Coenzyme Built From Two Nucleotides, and the Peptide Label Comes From the Clinic, Not the Chemistry
Is NAD+ a peptide? No. NAD+ is a coenzyme built from two nucleotides. What NAD+ is used for, what IV NAD+ studies found, and how it differs from SS-31.